NO20023914D0 - Preparater for anvendelse ved regulering av Parkin- genaktiviteten - Google Patents
Preparater for anvendelse ved regulering av Parkin- genaktivitetenInfo
- Publication number
- NO20023914D0 NO20023914D0 NO20023914A NO20023914A NO20023914D0 NO 20023914 D0 NO20023914 D0 NO 20023914D0 NO 20023914 A NO20023914 A NO 20023914A NO 20023914 A NO20023914 A NO 20023914A NO 20023914 D0 NO20023914 D0 NO 20023914D0
- Authority
- NO
- Norway
- Prior art keywords
- preparations
- regulating
- gene activity
- parkin gene
- parkin
- Prior art date
Links
- 101000619542 Homo sapiens E3 ubiquitin-protein ligase parkin Proteins 0.000 title abstract 2
- 230000000694 effects Effects 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title 1
- 230000001105 regulatory effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 101710176122 28 kDa heat- and acid-stable phosphoprotein Proteins 0.000 abstract 1
- 102100027336 Regenerating islet-derived protein 3-alpha Human genes 0.000 abstract 1
- 102000045222 parkin Human genes 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0001980A FR2805266B1 (fr) | 2000-02-17 | 2000-02-17 | Compositions utilisables pour reguler l'activite de la parkine |
| US19848900P | 2000-04-18 | 2000-04-18 | |
| PCT/FR2001/000461 WO2001060857A2 (fr) | 2000-02-17 | 2001-02-15 | Compositions utilisables pour reguler l'activite de la parkine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20023914D0 true NO20023914D0 (no) | 2002-08-16 |
| NO20023914L NO20023914L (no) | 2002-10-11 |
Family
ID=26212182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20023914A NO20023914L (no) | 2000-02-17 | 2002-08-16 | Preparater for anvendelse for regulering av aktiviteten til parkingenet |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7132396B2 (no) |
| EP (1) | EP1259606B1 (no) |
| KR (1) | KR100811926B1 (no) |
| AT (1) | ATE466083T1 (no) |
| AU (1) | AU2001235696A1 (no) |
| BR (1) | BR0108376A (no) |
| CA (1) | CA2400256C (no) |
| CY (1) | CY1111004T1 (no) |
| DE (1) | DE60141948D1 (no) |
| IL (3) | IL151211A0 (no) |
| MX (1) | MXPA02007869A (no) |
| NO (1) | NO20023914L (no) |
| NZ (1) | NZ520802A (no) |
| WO (1) | WO2001060857A2 (no) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1480994A1 (en) * | 2001-12-14 | 2004-12-01 | Incyte Genomics, Inc. | Neurotransmission-associated proteins |
| EP1610802A4 (en) * | 2003-02-18 | 2007-09-26 | Cedars Sinai Medical Center | PARKIN INTERACTIVE POLYPEPTIDES AND METHOD OF ADMINISTRATION |
| ES2490165T3 (es) * | 2007-09-11 | 2014-09-03 | Cancer Prevention And Cure, Ltd. | Método que facilita el diagnóstico y tratamiento del asma y cáncer de pulmón |
| CN109297780B (zh) * | 2018-10-23 | 2021-01-01 | 东华理工大学 | 一种液塑限联合测定法中的取样方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2394049A1 (en) * | 1999-12-21 | 2001-06-28 | Incyte Genomics, Inc. | Vesicle trafficking proteins |
| WO2001053312A1 (en) * | 1999-12-23 | 2001-07-26 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
| US20030220240A1 (en) * | 2000-12-21 | 2003-11-27 | Tang Y. Tom | Vesicle trafficking proteins |
-
2001
- 2001-02-15 EP EP01907820A patent/EP1259606B1/fr not_active Expired - Lifetime
- 2001-02-15 MX MXPA02007869A patent/MXPA02007869A/es active IP Right Grant
- 2001-02-15 BR BR0108376-7A patent/BR0108376A/pt active Search and Examination
- 2001-02-15 AT AT01907820T patent/ATE466083T1/de active
- 2001-02-15 KR KR1020027010630A patent/KR100811926B1/ko not_active Expired - Fee Related
- 2001-02-15 IL IL15121101A patent/IL151211A0/xx unknown
- 2001-02-15 DE DE60141948T patent/DE60141948D1/de not_active Expired - Lifetime
- 2001-02-15 WO PCT/FR2001/000461 patent/WO2001060857A2/fr active Application Filing
- 2001-02-15 NZ NZ520802A patent/NZ520802A/en not_active IP Right Cessation
- 2001-02-15 CA CA2400256A patent/CA2400256C/fr not_active Expired - Fee Related
- 2001-02-15 AU AU2001235696A patent/AU2001235696A1/en not_active Abandoned
- 2001-02-20 US US09/785,548 patent/US7132396B2/en not_active Expired - Fee Related
-
2002
- 2002-08-12 IL IL151211A patent/IL151211A/en not_active IP Right Cessation
- 2002-08-16 NO NO20023914A patent/NO20023914L/no not_active Application Discontinuation
-
2006
- 2006-03-28 US US11/390,195 patent/US8273548B2/en not_active Expired - Fee Related
-
2008
- 2008-08-07 IL IL193310A patent/IL193310A/en not_active IP Right Cessation
-
2010
- 2010-07-27 CY CY20101100700T patent/CY1111004T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20020155577A1 (en) | 2002-10-24 |
| EP1259606A2 (fr) | 2002-11-27 |
| US8273548B2 (en) | 2012-09-25 |
| BR0108376A (pt) | 2003-03-11 |
| CY1111004T1 (el) | 2015-06-11 |
| KR20020089352A (ko) | 2002-11-29 |
| CA2400256A1 (fr) | 2001-08-23 |
| EP1259606B1 (fr) | 2010-04-28 |
| IL151211A0 (en) | 2003-04-10 |
| NZ520802A (en) | 2005-02-25 |
| WO2001060857A2 (fr) | 2001-08-23 |
| DE60141948D1 (de) | 2010-06-10 |
| AU2001235696A1 (en) | 2001-08-27 |
| WO2001060857A3 (fr) | 2002-06-20 |
| MXPA02007869A (es) | 2003-02-10 |
| IL193310A (en) | 2011-12-29 |
| IL193310A0 (en) | 2011-08-01 |
| CA2400256C (fr) | 2014-09-09 |
| IL151211A (en) | 2010-05-31 |
| NO20023914L (no) | 2002-10-11 |
| US20060287230A1 (en) | 2006-12-21 |
| KR100811926B1 (ko) | 2008-03-10 |
| US7132396B2 (en) | 2006-11-07 |
| ATE466083T1 (de) | 2010-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2003089456A3 (en) | Peptide inhibitors of protein kinase c | |
| DE60040060D1 (de) | Kontrolle des proteinspiegels in eukaryotischen organismen | |
| WO2004054607A3 (de) | Stabile therapeutische proteine | |
| WO2002044320A3 (en) | Human elongase genes and uses thereof | |
| BR0312521A (pt) | Métodos para a separação e a purificação de fibrinogênio e de pelo menos uma outra proteìna e para a co-purificação de fibrinogênio e de fator xiii, uso de cromatografia de afinidade com ìon de metal imobilizado, fibrinogênio, kit farmacêutico, e, formulações farmacêutica e de fibrinogênio liofilizado | |
| PT1079849E (pt) | Utilizacao de proteinas hmg para a preparacao de medicamentos com actividade citotoxica | |
| AU2002212505A1 (en) | Dna expression vectors | |
| WO2001012661A3 (en) | RECEPTOR-MEDIATED UPTAKE OF AN EXTRACELLULAR BCL-xL FUSION PROTEIN INHIBITS APOPTOSIS | |
| WO2004099388A3 (en) | Cbl-b polypeptides, complexes and related methods | |
| CY1111004T1 (el) | Χρησιμες συνθεσεις για τη ρυθμιση της δρασης του γονιδιου της παρκινης | |
| AU7216498A (en) | Inhibitors of the urokinase receptor | |
| AU2001238064A1 (en) | 18477, a human protein kinase and uses therefor | |
| NO20006026L (no) | Fremgangsmåter og blandinger for modulering av angiogenese ved bruk av tyrosin kinase SRC | |
| WO2001064876A3 (en) | Human schizophrenia gene | |
| AU2002245255A1 (en) | Regulation of target protein activity through modified proteins | |
| DE69738600D1 (de) | Neuroaktive peptide | |
| AU2001249267A1 (en) | Methods and compositions for elucidating protein expression profiles in cells | |
| BR9813102A (pt) | Derivados de ácido metilenobisfosfÈnico novos | |
| WO1999050671A3 (en) | Toso as a target for drug screening | |
| DE60120187D1 (de) | Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen | |
| DE60032161D1 (de) | P-glycoproteine und ihre verwendungen | |
| WO2001057186A3 (en) | Methods and compositions for diagnosis and treatment of cancer based on esf | |
| WO2004047854A3 (en) | Methods for the treatment of alzheimers disease and compositions therefore | |
| WO2003059374A3 (de) | Verwendung von dimer-spezifischen nuklear-lokalisations-signalpeptiden (dsnls) abgeleitet aus der stat dna bindungsdomäne | |
| WO2001053351A3 (en) | Apoptin bindendes protein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |